Profit Attributable to the Owners of the Company Increased by 153.3% Actively Develop New Products Reform and Replenish the Sales Organisation Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”,…
The Group’s Revenue Up to HK$913 Million More than 30 approved studies are in progress Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, Stock Code: 950), an integrated research-driven…
Profit attributable to the owners of the Company increased significantly by 79.9% to approximately HK$418 million; Sales exceeded HK$1.1 billion; Obtained substantial breakthrough in research and development HONG KONG –…
